ORAGENICS, INC. Earnings Per Share, Basic and Diluted
ORAGENICS, INC. (OGEN) reported Earnings Per Share, Basic and Diluted of -$0.14 per share for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-24.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-03-24
- ORAGENICS, INC. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.04.
- ORAGENICS, INC. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.03.
- ORAGENICS, INC. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.05.
- ORAGENICS, INC. earnings per share, basic and diluted for the quarter ending 2020-12-31 was -$0.04.
- ORAGENICS, INC. earnings per share, basic and diluted for fiscal 2021 was -$0.14.
- ORAGENICS, INC. earnings per share, basic and diluted for fiscal 2020 was -$0.47.
- ORAGENICS, INC. earnings per share, basic and diluted for fiscal 2019 was -$0.37.
- ORAGENICS, INC. earnings per share, basic and diluted for fiscal 2018 was -$0.87.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-12-31 | -$0.14 10-K · filed 2022-03-24 | |||||||
| 2021-09-30 | -$0.04 10-Q · filed 2021-11-15 | -$0.12 10-Q · filed 2021-11-15 | ||||||
| 2021-06-30 | -$0.03 10-Q · filed 2021-08-16 | -$0.08 10-Q · filed 2021-08-16 | ||||||
| 2021-03-31 | -$0.05 10-Q · filed 2021-05-03 | |||||||
| 2020-12-31 | -$0.04 10-K · filed 2021-03-01 | -$0.47 10-K · filed 2022-03-24 | ||||||
| 2020-09-30 | -$0.08 10-Q · filed 2021-11-15 | -$0.42 10-Q · filed 2021-11-15 | ||||||
| 2020-06-30 | -$0.24 10-Q · filed 2021-08-16 | -$0.36 10-Q · filed 2021-08-16 | ||||||
| 2020-03-31 | -$0.11 10-Q · filed 2021-05-03 | |||||||
| 2019-12-31 | -$0.08 10-K · filed 2021-03-01 | -$0.16 derived: net income ÷ weighted average shares · filed 2021-03-01 | -$0.27 derived: net income ÷ weighted average shares · filed 2021-03-01 | -$0.37 10-K · filed 2021-03-01 | ||||
| 2019-09-30 | -$0.08 10-K · filed 2021-03-01 | -$0.19 derived: net income ÷ weighted average shares · filed 2020-11-10 | -$0.29 10-Q · filed 2020-11-10 | -$0.39 derived: net income ÷ weighted average shares · filed 2020-11-10 | ||||
| 2019-06-30 | -$0.10 10-K · filed 2021-03-01 | -$0.21 10-Q · filed 2020-08-14 | -$0.31 derived: net income ÷ weighted average shares · filed 2020-08-14 | -$0.51 derived: net income ÷ weighted average shares · filed 2020-08-14 | ||||
| 2019-03-31 | -$0.11 10-K · filed 2021-03-01 | -$0.20 derived: net income ÷ weighted average shares · filed 2020-05-15 | -$0.43 derived: net income ÷ weighted average shares · filed 2020-05-15 | -$0.65 derived: net income ÷ weighted average shares · filed 2020-05-15 | ||||
| 2018-12-31 | -$0.09 10-K · filed 2020-03-04 | -$0.34 derived: net income ÷ weighted average shares · filed 2020-03-04 | -$0.59 derived: net income ÷ weighted average shares · filed 2020-03-04 | -$0.87 10-K · filed 2020-03-04 | ||||
| 2018-09-30 | -$0.35 10-K · filed 2020-03-04 | -$0.72 derived: net income ÷ weighted average shares · filed 2020-03-04 | -$1.12 10-Q · filed 2019-11-14 | -$1.44 derived: net income ÷ weighted average shares · filed 2020-03-04 | ||||
| 2018-06-30 | -$0.38 10-Q · filed 2018-08-13 | -$0.80 10-Q · filed 2019-08-14 | -$1.10 derived: net income ÷ weighted average shares · filed 2020-03-04 | -$1.52 derived: net income ÷ weighted average shares · filed 2020-03-04 | ||||
| 2018-03-31 | -$0.42 10-K · filed 2020-03-04 | -$0.72 derived: net income ÷ weighted average shares · filed 2020-03-04 | -$1.14 derived: net income ÷ weighted average shares · filed 2020-03-04 | |||||
| 2017-12-31 | -$0.30 derived: net income ÷ weighted average shares · filed 2019-03-29 | -$0.72 derived: net income ÷ weighted average shares · filed 2019-03-29 | -$1.37 10-K · filed 2019-03-29 | |||||
| 2017-09-30 | -$0.42 10-Q · filed 2018-11-13 | -$0.04 10-Q · filed 2017-10-31 | -$1.07 10-Q · filed 2018-11-13 | -$0.11 10-Q · filed 2017-10-31 | ||||
| 2017-06-30 | -$0.25 10-Q · filed 2018-08-13 | -$0.02 10-Q · filed 2017-08-14 | -$0.65 10-Q · filed 2018-08-13 | -$0.07 10-Q · filed 2017-08-14 | ||||
| 2017-03-31 | -$0.40 10-Q · filed 2018-05-15 | -$0.04 10-Q · filed 2017-05-15 | ||||||
| 2016-12-31 | -$1.57 10-K · filed 2018-02-16 | -$0.16 10-K · filed 2017-02-27 | ||||||
| 2016-09-30 | -$0.04 10-Q · filed 2017-10-31 | -$0.10 10-Q · filed 2017-10-31 | ||||||
| 2016-06-30 | -$0.01 10-Q · filed 2017-08-14 | -$0.06 10-Q · filed 2017-08-14 | ||||||
| 2016-03-31 | -$0.05 10-Q · filed 2017-05-15 | |||||||
| 2015-12-31 | -$0.06 10-K · filed 2016-03-30 | -$0.32 10-K · filed 2017-02-27 | ||||||
| 2015-09-30 | -$0.05 10-Q · filed 2016-11-14 | -$0.26 10-Q · filed 2016-11-14 | ||||||
| 2015-06-30 | -$0.17 10-Q · filed 2016-08-15 | -$0.21 10-Q · filed 2016-08-15 | ||||||
| 2015-03-31 | -$0.04 10-Q · filed 2016-05-16 | |||||||
| 2014-12-31 | -$0.03 10-K · filed 2016-03-30 | -$0.16 10-K · filed 2016-03-30 | ||||||
| 2014-09-30 | -$0.03 10-K · filed 2016-03-30 | -$0.13 10-Q · filed 2015-11-06 | ||||||
| 2014-06-30 | -$0.05 10-K · filed 2016-03-30 | -$0.10 10-Q · filed 2015-08-07 | ||||||
| 2014-03-31 | -$0.05 10-K · filed 2016-03-30 | |||||||
| 2013-12-31 | -$0.09 10-K · filed 2015-02-27 | -$0.56 10-K · filed 2015-02-27 | ||||||
| 2013-09-30 | -$0.34 10-K · filed 2015-02-27 | -$0.47 10-Q · filed 2014-11-03 | ||||||
| 2013-06-30 | -$0.08 10-K · filed 2015-02-27 | -$0.13 10-Q · filed 2014-08-07 | ||||||
| 2013-03-31 | -$0.06 10-K · filed 2015-02-27 | |||||||
| 2012-12-31 | -$0.07 10-K · filed 2014-02-28 | -$0.74 10-K · filed 2014-02-28 | ||||||
| 2012-09-30 | -$0.11 10-K · filed 2014-02-28 | -$0.76 10-Q · filed 2013-10-25 | ||||||
| 2012-06-30 | -$0.52 10-K · filed 2014-02-28 | -$0.86 10-Q · filed 2013-08-12 | ||||||
| 2012-03-31 | -$0.25 10-K · filed 2014-02-28 | |||||||
| 2011-12-31 | -$0.33 10-K · filed 2013-03-26 | -$1.34 10-K · filed 2013-03-26 | ||||||
| 2011-09-30 | -$0.32 10-K · filed 2013-03-26 | -$1.01 10-Q · filed 2012-11-14 | ||||||
| 2011-06-30 | -$0.42 10-K · filed 2013-03-26 | -$0.69 10-Q · filed 2012-08-10 | ||||||
| 2011-03-31 | -$0.28 10-K · filed 2013-03-26 | -$0.28 10-Q · filed 2012-05-15 | ||||||
| 2010-12-31 | -$1.42 10-K · filed 2012-04-16 | |||||||
| 2010-09-30 | -$0.34 10-Q · filed 2011-11-14 | -$1.03 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |